Response to Comment on Sakaki et al. Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes

Kentaro Sakaki, Takaaki Murakami, Daisuke Yabe, Nobuya Inagaki

Open source

DOI
10.2337/dbi26-0017
Published
2026-06-22
Container
Diabetes
Publisher
American Diabetes Association
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2337/dbi26-0017,
  title = {Response to Comment on Sakaki et al. Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes},
  author = {Kentaro Sakaki and Takaaki Murakami and Daisuke Yabe and Nobuya Inagaki},
  year = {2026},
  journal = {Diabetes},
  doi = {10.2337/dbi26-0017},
  url = {https://doi.org/10.2337/dbi26-0017}
}

RIS

TY  - JOUR
TI  - Response to Comment on Sakaki et al. Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes
AU  - Kentaro Sakaki
AU  - Takaaki Murakami
AU  - Daisuke Yabe
AU  - Nobuya Inagaki
PY  - 2026
JO  - Diabetes
DO  - 10.2337/dbi26-0017
UR  - https://doi.org/10.2337/dbi26-0017
ER  - 

APA

Sakaki, K., Murakami, T., Yabe, D., & Inagaki, N. (2026). Response to Comment on Sakaki et al. Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes. Diabetes. https://doi.org/10.2337/dbi26-0017

Source records